PRICE T ROWE ASSOCIATES INC /MD/ - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$578
-49.9%
50,378
+10.6%
0.00%
Q2 2023$1,153
-16.4%
45,540
+6.4%
0.00%
Q1 2023$1,379
+72.2%
42,793
-1.3%
0.00%
Q4 2022$801
-99.9%
43,365
-1.4%
0.00%
Q3 2022$1,188,000
+124.2%
43,975
+14.7%
0.00%
Q2 2022$530,000
-28.3%
38,332
+1.1%
0.00%
Q1 2022$739,000
+40.0%
37,904
+17.2%
0.00%
Q4 2021$528,000
-23.4%
32,353
+30.7%
0.00%
Q3 2021$689,000
-5.4%
24,745
+0.8%
0.00%
Q2 2021$728,000
+17.0%
24,545
+10.4%
0.00%
Q1 2021$622,000
-24.7%
22,242
-23.7%
0.00%
Q4 2020$826,000
+47.2%
29,146
+30.6%
0.00%
Q3 2020$561,000
+16.6%
22,310
+13.2%
0.00%
Q2 2020$481,000
+70.0%
19,700
+2.9%
0.00%
Q1 2020$283,000
+7.2%
19,139
+17.8%
0.00%
Q4 2019$264,000
-26.5%
16,243
-41.1%
0.00%
Q3 2019$359,000
+1.1%
27,593
+0.9%
0.00%
Q2 2019$355,000
-17.2%
27,346
+0.5%
0.00%
Q1 2019$429,000
+53.8%
27,207
+96.5%
0.00%
Q4 2018$279,00013,8450.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$48,000,00065.50%
Essex Woodlands Management, Inc. 3,842,047$118,335,00025.90%
Rhenman & Partners Asset Management AB 203,181$6,258,0000.77%
EAM Global Investors LLC 44,898$1,383,0000.72%
Fosun International Ltd 319,313$9,835,0000.62%
EAM Investors, LLC 113,096$3,483,0000.58%
ArrowMark Colorado Holdings LLC 1,735,699$53,460,0000.53%
Perceptive Advisors 618,957$19,064,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 111,360$3,430,0000.45%
Schonfeld Strategic Advisors LLC 83,700$2,578,0000.19%
View complete list of REVANCE THERAPEUTICS INC shareholders